News | Artificial Intelligence | February 23, 2024

Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve

FDA-cleared Cleerly ISCHEMIA will assist healthcare professionals in clinical diagnosis and decision making for coronary artery disease

FDA-cleared Cleerly ISCHEMIA will assist healthcare professionals in clinical diagnosis and decision making for coronary artery disease

February 23, 2024 — Cleerly, the company creating a new standard of care to aid in the diagnosis of heart disease, announced that its recently U.S. Food and Drug Administration (FDA)-cleared Cleerly ISCHEMIA software device applied to a non-invasive coronary CT angiogram (CCTA) can be billed using the new Category I CPT code 75580. The American Medical Association (AMA) defines this service as a complementary augmented intelligence tool for noninvasive estimates of fractional flow reserve (FFR) to assist healthcare professionals in clinical diagnosis and decision making. The Category I CPT code is an addition to the Category III CPT codes (CPT 0623T, 0624T, 0625T, 0626T) used for reporting Cleerly’s advanced coronary atherosclerosis analysis.

Effective January 1, 2024, the AMA published updates to its CPT code set to include a new Category I CPT code 75580, described as, "Noninvasive estimate of coronary fractional flow reserve derived from augmentative software analysis of the data set from a coronary computed tomography angiography, with interpretation and report by a physician or other qualified healthcare professional."  The Cleerly ISCHEMIA software outputs an index with its "threshold equivalent to invasive FFR >0.80 vs. ≤0.80 as identified in professional societal practice guidelines." 1

The Cleerly ISCHEMIA software outputs data that is augmentative to support clinical decision making by both the interpreting imaging physician as well as the treating physician. This analysis enables the imaging and treating physicians to interrogate each lesion across all coronary vessels in order to perform lesion-by-lesion mapping of actionable anatomic and physiologic findings of coronary artery disease in order to offer greater understanding of the pathology, and encourage the development of a personalized treatment management plan for the patient.

"The Cleerly ISCHEMIA software provides noninvasive estimates of FFR values that help healthcare professionals make critical decisions in the management of patients with suspected coronary artery disease," said James P. Earls, MD, Chief Medical Officer of Cleerly. "Cleerly ISCHEMIA was purposely designed to output estimates of FFR values that are guideline-recommended by professional societies, and to allow comprehensive mapping of both anatomic and physiologic data for each and every coronary lesion across the entire vascular tree."

Prior studies have demonstrated the independent and incremental benefit of Cleerly ISCHEMIA applied to CCTA beyond traditional assessment. The application of Cleerly ISCHEMIA supports improvements in physician certainty, guides medical therapy decision making, and reduces unnecessary invasive and non-invasive testing.2-6

For more information: www.cleerlyhealth.com

References:

  1. FDA 510(k) Number K231335 Summary for Cleerly ISCHEMIA.
  2. Nurmohamed NS, Danad I, Jukema R. High Diagnostic Accuracy Of AI-Ischemia in Comparison To PET, FFR-CT, SPECT, and Invasive FFR: A PACIFIC Sub-Study. Sponsored by Cleerly and Presented at the American College of Cardiology Annual Scientific Meeting New Orleans LA 2023.
  3. van Rosendael A, Danad I, CREDENCE study group, PACIFIC study group. Derivation, Validation and Prognostic Assessment of an AI-Based Algorithm for Determination of Coronary Ischemia: The CREDENCE and PACIFIC Trial. in European Association of Cardiovascular Imaging: Late Breaking Clinical Research and Trials. 2023. Barcelona, Spain.
  4. Chiou A, Hermel M, Miller G et al. Cleerly® Vs. Heartflow® vs. Site Read in The Per-Vessel Prediction of Adenosine FFR ≤0.80 With Plaque Features Associated with False Positives. Presented at the American College of Cardiology Annual Scientific Meeting New Orleans LA 2023
  5. Karlsberg RP, Gonzalez Quesada C, Samuels B et al. High diagnostic accuracy of a novel artificial intelligence guided quantitative coronary computed tomography algorithm for predicting myocardial ischemia. Presented at the Society of Cardiovascular Computed Tomography Annual Scientific Meeting Boston MA 2023. Journal of Cardiovascular Computed Tomography Vol. 17 Issue 4 Supplement S28–S29 Published in issue: July, 2023.
  6. Bär S, Nabeta T, Maaniitty T. Prognostic Value of a Novel Artificial Intelligence-Based Coronary Computed Tomography Angiography-Derived Ischemia Algorithm for Patients with Suspected Coronary Artery Disease. Eur Heart J Cardiovasc Imaging. 2023 Dec 12:jead339. Epub ahead of print. PMID: 38084894.

Related Content

News | Cardiac Imaging

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Home July 28, 2025
Home
News | Cardiac Imaging

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

Home July 25, 2025
Home
News | Cardiac Imaging

July 17, 2025— Heartflow, Inc. recently announced new data for its AI-enabled Heartflow Plaque Analysis, including final ...

Home July 17, 2025
Home
News | Cardiac Imaging

July 15, 2025 – Cleerly has announced that EviCore, a leading radiology benefit manager providing coverage guidelines to ...

Home July 16, 2025
Home
News | Cardiac Imaging

July 11, 2025 — Heartflow, Inc. has announced that its Heartflow Plaque Analysis will be included in updated cardiac ...

Home July 15, 2025
Home
News | Cardiac Imaging

July 9, 2025 — Cleerly, a leader in advanced cardiovascular imaging, will be presenting new research at the Society of ...

Home July 15, 2025
Home
News | Cardiac Imaging

Cleerly, a leader in cardiovascular imaging, today announced the promotions of two key executives to expanded leadership ...

Home July 02, 2025
Home
News | Cardiac Imaging

June 25, 2025 — Royal Philips and Methodist Hospitals recently announced the healthcare provider’s strategic investment ...

Home June 25, 2025
Home
News | Cardiac Imaging

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Home June 12, 2025
Home
News | Cardiac Imaging

April 1, 2025 — UltraSight recently announced the presentation at the American College of Cardiology (ACC) Annual ...

Home April 15, 2025
Home
Subscribe Now